Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wilhelm

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cell Death & Disease|April 2, 2019
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitorsMohamed Mahameed, Thomas Wilhelm, Odai Darawshi, et al.
Magnetic Resonance in Medicine|July 2, 2019
Cardiorenal sodium MRI at 7.0 Tesla using a 4/4 channel <sup>1</sup> H/<sup>23</sup> Na radiofrequency antenna arrayLaura Boehmert, Andre Kuehne, Helmar Waiczies, et al.
Nature Communications|March 13, 2020
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapyMohamed Mahameed, Shatha Boukeileh, Akram Obiedat, et al.
Epigenetics|February 19, 2016
Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemiaThomas Wilhelm, Daniel B Lipka, Tania Witte, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 3, 2020
Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla)Eva Oberacker, Andre Kuehne, Celal Oezerdem, et al.
Plos One|May 26, 2010
Reconstruction and validation of RefRec: a global model for the yeast molecular interaction networkTommi Aho, Henrikki Almusa, Jukka Matilainen, et al.
Investigational New Drugs|March 15, 2012
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemiasPatrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, et al.
Hematological Oncology|November 16, 2022
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemiaThomas Wilhelm, Marcelo A S Toledo, Ilka Simons, et al.
European Journal of Immunology|December 16, 2024
KIRA6 is an Effective and Versatile Mast Cell Inhibitor of IgE-mediated ActivationVeronika Wunderle, Thomas Wilhelm, Shatha Boukeileh, et al.
Blood|September 30, 2006
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approachStefan Balabanov, Artur Gontarewicz, Patrick Ziegler, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cell Death & Disease|April 2, 2019
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitorsMohamed Mahameed, Thomas Wilhelm, Odai Darawshi, et al.
Magnetic Resonance in Medicine|July 2, 2019
Cardiorenal sodium MRI at 7.0 Tesla using a 4/4 channel <sup>1</sup> H/<sup>23</sup> Na radiofrequency antenna arrayLaura Boehmert, Andre Kuehne, Helmar Waiczies, et al.
Nature Communications|March 13, 2020
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapyMohamed Mahameed, Shatha Boukeileh, Akram Obiedat, et al.
Epigenetics|February 19, 2016
Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemiaThomas Wilhelm, Daniel B Lipka, Tania Witte, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 3, 2020
Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla)Eva Oberacker, Andre Kuehne, Celal Oezerdem, et al.
Plos One|May 26, 2010
Reconstruction and validation of RefRec: a global model for the yeast molecular interaction networkTommi Aho, Henrikki Almusa, Jukka Matilainen, et al.
Investigational New Drugs|March 15, 2012
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemiasPatrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, et al.
Hematological Oncology|November 16, 2022
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemiaThomas Wilhelm, Marcelo A S Toledo, Ilka Simons, et al.
European Journal of Immunology|December 16, 2024
KIRA6 is an Effective and Versatile Mast Cell Inhibitor of IgE-mediated ActivationVeronika Wunderle, Thomas Wilhelm, Shatha Boukeileh, et al.
Blood|September 30, 2006
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approachStefan Balabanov, Artur Gontarewicz, Patrick Ziegler, et al.
Pageof 12